Pour une meilleure utilisation, nous vous conseillons d’activer Javascript dans votre navigateur.

VEGFR2/CD309 anticorps (AA 20-764)

VEGFR2 Reactivité: Humain WB, IHC, ELISA Hôte: Souris Monoclonal MM0002A-2F46 unconjugated

N° du produit ABIN1982927

Fiche de données

Antigène Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
Épitope
36

34

27

21

20

16

16

13

13

10

9

8

8

6

6

6

5

4

4

3

3

2

2

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1
AA 20-764
Reactivité
293

185

136

17

9

4

3

3

3

3

1

1

1

1

1

1

1

1

1

1
Humain
Hôte
281

54

18

2

1

1
Souris
Anticorps secondaires appropriés
Clonalité
276

81
Monoclonal
Conjugué
151

32

20

14

13

13

12

12

11

11

11

11

6

6

6

6

6

3

2

2

2

1

1

1

1

1

1

1
Cet anticorp VEGFR2/CD309 est non-conjugé
Application
214

127

91

87

56

27

26

21

19

14

13

12

9

7

7

4

3

2

2

2

2

1

1

1

1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Attributs du produit

Mouse anti human VEGFR-2

Immunogène

AA 20-764

Clone

MM0002A-2F46

Isotype

IgG1

Top Product

Discover our top product VEGFR2 Anticorps primaire
anti-VEGF Receptor 2 (VEGFR2) (AA 20-200) antibody
VEGFR2 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibody
VEGFR2 Reactivité: Humain WB, IF, FACS, IHC (p) Hôte: Lapin Polyclonal RB01536 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibody
VEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibody
VEGFR2 Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibody
VEGFR2 Reactivité: Humain WB, IHC, ELISA, IF, FACS Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibody
VEGFR2 Reactivité: Humain, Souris, Rat, Lapin ELISA, FACS, IHC (p), IF (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibody
VEGFR2 Reactivité: Humain WB, ELISA, FACS, ICC Hôte: Souris Monoclonal 4B4 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibody
VEGFR2 Reactivité: Humain WB, IHC, ELISA, FACS, ICC, Neut Hôte: Souris Monoclonal 1A9A3 unconjugated

anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibody
VEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated

anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibody
VEGFR2 Reactivité: Humain WB, IHC (p), ICC, IHC (fro) Hôte: Lapin Polyclonal unconjugated

Indications d'application

Optimal dilutions should be determined by each laboratory for each application.

Restrictions

For Research Use only
Format

Lyophilized

Reconstitution

200 µL of PBS, pH 7.4

Concentration

500 µg/mL

Buffer

Lyophilized from a solution containing PBS, pH 7.4

Stock

-20 °C
Antigène

VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Autre désignation

VEGFR-2 (VEGFR2 Produits)

Synonymes

anticorps CD309, anticorps FLK1, anticorps VEGFR, anticorps VEGFR2, anticorps 6130401C07, anticorps Flk-1, anticorps Flk1, anticorps Krd-1, anticorps Ly73, anticorps VEGFR-2, anticorps sVEGFR-2, anticorps Vegfr-2, anticorps FLK-1, anticorps flk-1, anticorps vegfr-2, anticorps KDR, anticorps FLK/KDR, anticorps flk1, anticorps flk1b, anticorps kdrb, anticorps si:busm1-205d10.1, anticorps si:ch211-254j6.1, anticorps si:ch211-278f21.4, anticorps wu:fc31a09, anticorps fk52c05, anticorps flk, anticorps kdr, anticorps kdra, anticorps vegfr2, anticorps vegfr4, anticorps vegr2, anticorps wu:fk52c05, anticorps kinase insert domain receptor, anticorps kinase insert domain protein receptor, anticorps vascular endothelial growth factor receptor kdr-like, anticorps kinase insert domain receptor (a type III receptor tyrosine kinase), anticorps kinase insert domain receptor like, anticorps KDR, anticorps Kdr, anticorps LOC100136647, anticorps kdr, anticorps kdrl

UniProt

P35968

Pathways

Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling